Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
Are there any recommendations for restarting JAKi after a provoked DVT?
Related Questions
Do you avoid tocilizumab in patients with prior bariatric surgery given the risk of GI perforation?
What is your approach for cancer screening for elderly onset RA?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
How do you approach restarting cDMARDS/bDMARDS in a patient with active RA after incidence of disseminated CNS VZV infection while on tofacitinib?
Do you use the peri-operative management of biologics and DMARDs guidelines, which were mainly based on total hip and knee replacement surgeries, for all peri-operative surgical management?
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
When do you recommend initiation of targeted therapies in active RA with history of malignancy?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
How do you approach monitoring when using combination JAK inhibitors and methotrexate in RA?
